Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.
NEW YORK — Four New York shops remain in the running to handle ad duties on FluMist, a new flu vaccine from Wyeth Laboratories and MedImmune that will be delivered as a nasal spray, sources said.
The shops are Foote, Cone & Belding, McCann-Erickson, Saatchi & Saatchi and Euro RSCG MVBMS Partners, said sources. Final presentations are scheduled for the week of Oct. 14, with a decision shortly thereafter.
Billings have not been determined but sources estimated that the client would spend $30-40 million to launch the brand.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in